Dominick J Angiolillo (Angiolillo Dominick Joseph, Dominick Angiolillo)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 95

Top Topics

Atrial Fibrillation

Percutaneous Coronary Intervention

Antiplatelet Therapy

Patients Undergoing

Top Venues

Nature reviews. Cardiology

Thrombosis and haemostasis

Journal of the American Heart Association

Expert review of cardiovascular therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association 13 (12) (2024)
Miriam Euper, Jürgen Schreieck, Mareike Bladt, Monika Zdanyte, Andreas Goldschmied, Manuel Sigle, Dominick J Angiolillo, Diana Adrienne Gorog, Mia Ravn Jacobsen, Rikke Sørensen, Dominik Rath, Meinrad Gawaz, Tobias Geisler
Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System. Thrombosis and haemostasis (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology 21 (8) (2024)
Luis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity. Thrombosis and haemostasis (2024)
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association 13 (12) (2024)
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association (2024)
Claudio Laudani, Davide Capodanno, Dominick J Angiolillo
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke. Expert opinion on pharmacotherapy 25 (10) (2024)
Claudio Laudani, Davide Capodanno, Dominick J Angiolillo
The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke. Expert opinion on pharmacotherapy (2024)
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte, Yan Gong, Joseph S Rossi, Amber L Beitelshees, George A Stouffer, And Craig R Lee, Dominick J Angiolillo, Larisa H Cavallari
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction. Clinical pharmacology and therapeutics (2024)
Larisa H Cavallari, And Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas, Yan Gong, Caitrin W McDonough, Petr Starostik, Maryam Jamal AlSaeed, Latonya Been, Natasha Kulick, Jean Gabriel Malave, Ian R Mulrenin, Anh B Nguyen, Joshua N Terrell, Grace Tillotson, Amber L Beitelshees, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies. Clinical and translational science 17 (8) (2024)
Mattia Galli, Giovanni Occhipinti, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Salvatore Brugaletta, Davide Capodanno, Sebastiano Sciarretta, Dominick J Angiolillo
Therapeutic Potential of FXI Inhibitors: Hype or Hope? Drugs (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology 21 (8) (2024)
Maryam Jamal AlSaeed, Cameron D Thomas, Francesco Franchi, Ellen C Keeley, Julio D Duarte, Yan Gong, Joseph S Rossi, Amber L Beitelshees, George A Stouffer, And Craig R Lee, Dominick J Angiolillo, Larisa H Cavallari
Evaluating the Effect of Estimating Renal Function With the CKD-EPI 2021 Equation on the ABCD-GENE Score for Clopidogrel Response Prediction. Clinical pharmacology and therapeutics (2024)
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association 13 (12) (2024)
Alessandro Spirito, Sriya L Krishnan, Davide Capodanno, Dominick J Angiolillo, Roxana Mehran
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions 17 (4) (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology (2024)
Luis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity. Thrombosis and haemostasis 124 (6) (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology (2024)
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association 13 (12) (2024)
Mattia Galli, Sergio Terracina, Eleonora Schiera, Massimo Mancone, Luigi Frati, Dominick J Angiolillo, Fabio M Pulcinelli
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital. Journal of thrombosis and thrombolysis (2024)
Alessandro Spirito, Sriya L Krishnan, Davide Capodanno, Dominick J Angiolillo, Roxana Mehran
Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention. Circulation. Cardiovascular interventions 17 (4) (2024)
Luis Ortega-Paz, Francesco Franchi, Dominick J Angiolillo
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity. Thrombosis and haemostasis 124 (6) (2024)
Larisa H Cavallari, And Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas, Yan Gong, Caitrin W McDonough, Petr Starostik, Maryam Jamal AlSaeed, Latonya Been, Natasha Kulick, Jean Gabriel Malave, Ian R Mulrenin, Anh B Nguyen, Joshua N Terrell, Grace Tillotson, Amber L Beitelshees, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies. Clinical and translational science 17 (8) (2024)
Kayla R Tunehag, Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Yan Gong, Richard A Kerensky, Caitrin W McDonough, Anh B Nguyen, Luis Ortega-Paz, Sanjay Venkatesh, Yehua Wang, Julie A Johnson, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo, Larisa H Cavallari, And Craig R Lee
CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association 13 (12) (2024)
Larisa H Cavallari, And Craig R Lee, Francesco Franchi, Ellen C Keeley, Joseph S Rossi, Cameron D Thomas, Yan Gong, Caitrin W McDonough, Petr Starostik, Maryam Jamal AlSaeed, Latonya Been, Natasha Kulick, Jean Gabriel Malave, Ian R Mulrenin, Anh B Nguyen, Joshua N Terrell, Grace Tillotson, Amber L Beitelshees, Almut G Winterstein, George A Stouffer, Dominick J Angiolillo
Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies. Clinical and translational science 17 (8) (2024)
Azita Hajhossein Talasaz, Parham Sadeghipour, Luis Ortega-Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig Beavers, John Fanikos, John William Eikelboom, Deborah M Siegal, Manuel Monreal, David Jiménez, Muthiah Vaduganathan, Lana A Castellucci, Adam Cuker, Geoffery D Barnes, Jean M Connors, Eric A Secemsky, Benjamin W Van Tassell, Raffaele De Caterina, Jacob E Kurlander, Ali Aminian, Gregory Piazza, Samuel Z Goldhaber, Lisa Moores, Saskia Middeldorp, Ajay J Kirtane, Mitchell S V Elkind, Dominick J Angiolillo, Stavros Konstantinides, Gregory Y H Lip, Gregg W Stone, Mary Cushman, Harlan M Krumholz, Roxana Mehran, Deepak L Bhatt, Behnood Bikdeli
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature reviews. Cardiology 21 (8) (2024)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, Charles Micheal Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis. Thrombosis and haemostasis (2023)
Antonio Greco, Simone Finocchiaro, Dominick J Angiolillo, Davide Capodanno
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Expert opinion on pharmacotherapy (2023)
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda Maldonado, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Lisa K Jennings, Dominick J Angiolillo
Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban. Thrombosis and haemostasis (2023)
Giovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, Davide Capodanno
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes. Expert opinion on drug safety (2023)
Mattia Galli, Giampaolo Niccoli, Giovanni Luigi De Maria, Salvatore Brugaletta, Rocco Antonio Montone, Rocco Vergallo, Stefano Benenati, Giulia Magnani, Domenico D'Amario, Italo Porto, Francesco Burzotta, Antonio Abbate, Dominick J Angiolillo, Filippo Crea
Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nature reviews. Cardiology (2023)
Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo
Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clinical pharmacokinetics (2023)
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, Usman Baber, Deepak L Bhatt, Piera Capranzano, Jean-Philippe Collet, Thomas Cuisset, Giuseppe De Luca, Leonardo De Luca, Andrew Farb, Francesco Franchi, C Michael Gibson, Joo-Yong Hahn, Meyong-Ki Hong, Stefan K James, Adnan Kastrati, Takeshi Kimura, Pedro Alves Lemos Neto, Renato Deláscio Lopes, Adrian Magee, Ryosuke Matsumura, Shuichi Mochizuki, Michelle L O'Donoghue, Naveen L Pereira, Sunil V Rao, Fabiana Rollini, Yuko Shirai, Dirk Sibbing, Pieter C Smits, Phillippe Gabriel Steg, Robert F Storey, Jurrien M Ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W J C Serruys, Robert W Yeh, Marie-Claude Morice, Dominick J Angiolillo
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium. Circulation 147 (25) (2023)
Marco Spagnolo, Dominick J Angiolillo, Davide Capodanno
Evaluating the pharmacokinetic and pharmacodynamic impact of different modes of ticagrelor administration. Expert opinion on drug metabolism & toxicology (2023)
Mattia Galli, Giampaolo Niccoli, Giovanni Luigi De Maria, Salvatore Brugaletta, Rocco Antonio Montone, Rocco Vergallo, Stefano Benenati, Giulia Magniani, Domenico D'Amario, Italo Porto, Francesco Burzotta, Antonio Abbate, Dominick J Angiolillo, Filippo Crea
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nature reviews. Cardiology (2023)
Claudio Laudani, Davide Capodanno, Dominick J Angiolillo
Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management. Expert opinion on drug safety (2023)
Mattia Galli, Dominick J Angiolillo
Efficacy and safety of lidocaine vs. opioid analgesics in acute coronary syndromes. European heart journal. Acute cardiovascular care 12 (1) (2023)
Luis Ortega-Paz, Roxana Mehran, Dominick J Angiolillo
North American Perspective on the 2023 ESC Guidelines for the Management of ACS. European heart journal. Acute cardiovascular care (2023)
Antonio Greco, Simone Finocchiaro, Dominick J Angiolillo, Davide Capodanno
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Expert opinion on pharmacotherapy (2023)
Mattia Galli, Marco Bernardi, Luis Ortega-Paz, Roberto Nerla, Domenico D'Amario, Francesco Franchi, Giuseppe Biondi-Zoccai, Dominick J Angiolillo
Bivalirudin in acute coronary syndromes. Expert review of cardiovascular therapy (2023)
Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo
Correction to: Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clinical pharmacokinetics (2023)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, C Michael Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI inhibitors in early clinical trials: a meta-analysis. Thrombosis and haemostasis (2023)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Luis Ortega-Paz, Salvatore Giordano, Davide Capodanno, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo
Clinical Pharmacokinetics and Pharmacodynamics of CSL112. Clinical pharmacokinetics (2023)
Davide Capodanno, Dominick J Angiolillo
Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention. Circulation 147 (2) (2023)
Mattia Galli, Dominick J Angiolillo
How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention? Expert review of clinical pharmacology (2023)
Davide Capodanno, Dominick J Angiolillo
Personalised antiplatelet therapies for coronary artery disease: what the future holds. European heart journal (2023)
Mattia Galli, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention. Pharmacogenomics 23 (13) (2022)
Antonio Greco, Maria Sara Mauro, Davide Capodanno, Dominick J Angiolillo
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI. Reviews in cardiovascular medicine 23 (10) (2022)
Tobias Koch, Shqipdona Lahu, J J Coughlan, Salvatore Cassese, Felix Voll, Gjin Ndrepepa, Maurizio Menichelli, Christian M Valina, Rayyan Hemetsberger, Bernhard Witzenbichler, Isabell Bernlochner, Michael Joner, Erion Xhepa, Katharina Mayer, Thorsten Kessler, Karl-Ludwig Laugwitz, Gert Richardt, Heribert Schunkert, Dominick J Angiolillo, Dirk Sibbing, Adnan Kastrati, Sebastian Kufner
Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. Thrombosis and haemostasis (2022)
Antonio Greco, Maria Sara Mauro, Davide Capodanno, Dominick J Angiolillo
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCI. Reviews in cardiovascular medicine 23 (10) (2022)
Dario Bongiovanni, Nina Schreiner, Rosanna Gosetti, Katharina Mayer, Dominick J Angiolillo, Dirk Sibbing, Stefan Holdenrieder, Aida Anetsberger, Moritz von Scheidt, Heribert Schunkert, Karl-Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, Isabel Wustrow, Isabell Bernlochner
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arteriosclerosis, thrombosis, and vascular biology 43 (2) (2022)
Jennifer A Rymer, Deepak L Bhatt, Dominick J Angiolillo, Miguel Diaz, Kirk N Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El-Sabae, Carmen Dell'Anna, Linda Davidson-Ray, Jeffrey B Washam, E Magnus Ohman, Tracy Y Wang
Cangrelor Use Patterns and Transition to Oral P2Y 12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry. Journal of the American Heart Association 11 (11) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Tobias Geisler, Lisa K Jennings, Theodore A Bass, Dominick J Angiolillo
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Thrombosis and haemostasis 122 (8) (2022)
Davide Capodanno, Usman Baber, Deepak L Bhatt, Jean-Philippe Collet, George Dangas, Francesco Franchi, Charles Michael Gibson, Hyeon-Cheol Gwon, Adnan Kastrati, Takeshi Kimura, Pedro A Lemos, Renato D Lopes, Roxana Mehran, Michelle L O'Donoghue, Sunil V Rao, Fabiana Rollini, Patrick W Serruys, Philippe G Steg, Robert F Storey, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Dominick J Angiolillo
P2Y 12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention. Nature reviews. Cardiology 19 (12) (2022)
Luis Ortega-Paz, Mattia Galli, Dominick J Angiolillo
Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19. European heart journal. Cardiovascular pharmacotherapy 8 (3) (2022)
Placido Maria Mazzone, Dominick J Angiolillo, Davide Capodanno
Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk. Expert review of cardiovascular therapy 20 (10) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Tobias Geisler, Lisa K Jennings, Theodore A Bass, Dominick J Angiolillo
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Yaling Han, Bimmer E P M Claessen, Shao-Liang Chen, Qiu Chunguang, Yu Jie Zhou, Yawei Xu, Lin Hailong, Jiyan Chen, Wu Qiang, Ruiyan Zhang, Suxin Luo, Yongjun Li, Jianhua Zhu, Xianxian Zhao, Xiang Cheng, Jian'an Wang, Xi Su, Jianhong Tao, Yingxian Sun, Geng Wang, Yi Li, Liya Bian, Ridhima Goel, Samantha Sartori, Zhongjie Zhang, Dominick J Angiolillo, David Joel Cohen, C Michael Gibson, Adnan Kastrati, Mitchell Krucoff, Shamir R Mehta, E Magnus Ohman, Phillippe Gabriel Steg, Yuqi Liu, George D Dangas, Samin K Sharma, Usman Baber, Roxana Mehran
Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy. Circulation. Cardiovascular interventions 15 (4) (2022)
Dario Bongiovanni, Nina Schreiner, Rosanna Gosetti, Katharina Mayer, Dominick J Angiolillo, Dirk Sibbing, Stefan Holdenrieder, Aida Anetsberger, Moritz von Scheidt, Heribert Schunkert, Karl-Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, Isabel Wustrow, Isabell Bernlochner
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arteriosclerosis, thrombosis, and vascular biology (2022)
Shqipdona Lahu, Antonia Presch, Gjin Ndrepepa, Maurizio Menichelli, Christian Valina, Rayyan Hemetsberger, Bernhard Witzenbichler, Isabell Bernlochner, Michael Joner, Erion Xhepa, Alexander Hapfelmeier, Sebastian Kufner, Nonglag Rifatov, Hendrik B Sager, Katharina Mayer, Thorsten Kessler, Karl-Ludwig Laugwitz, Gert Richardt, Heribert Schunkert, Franz-Josef Neumann, Dirk Sibbing, Dominick J Angiolillo, Adnan Kastrati, Salvatore Cassese
Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk. Circulation. Cardiovascular interventions 15 (10) (2022)
Francesco Franchi, David J Schneider, Jayne Prats, Weihong Fan, Fabiana Rollini, Latonya Been, Heidi S Taatjes-Sommer, Deepak L Bhatt, Efthymios N Deliargyris, Dominick J Angiolillo
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study. Journal of thrombosis and thrombolysis 54 (3) (2022)
Dominick J Angiolillo, Jayne Prats, Efthymios N Deliargyris, David J Schneider, James Scheiman, Carey Kimmelstiel, Ph Gabriel Steg, Mark Alberts, Todd Rosengart, Roxana Mehran, Deepak L Bhatt
Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation. Clinical pharmacokinetics 61 (4) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Domenico D'Amario, Raffaele De Caterina, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications. Expert review of clinical pharmacology (2022)
Dario Bongiovanni, Nina Schreiner, Rosanna Gosetti, Katharina Mayer, Dominick J Angiolillo, Dirk Sibbing, Stefan Holdenrieder, Aida Anetsberger, Moritz von Scheidt, Heribert Schunkert, Karl-Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, Isabel Wustrow, Isabell Bernlochner
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arteriosclerosis, thrombosis, and vascular biology 43 (2) (2022)
Mattia Galli, Luis Ortega-Paz, Dominick J Angiolillo
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot. European heart journal (2022)
Mattia Galli, Dominick J Angiolillo
Efficacy and Safety of Lidocaine versus Opioid Analgesics in Acute Coronary Syndromes. European heart journal. Acute cardiovascular care (2022)
Davide Capodanno, Dominick J Angiolillo, Ryan J Lennon, Shaun G Goodman, Sang-Wook Kim, Fearghas O'Cochlain, Derek Y F So, John Sweeney, Charanjit S Rihal, Michael Farkouh, Naveen L Pereira
ABCD-GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR-PCI Trial. Journal of the American Heart Association 11 (4) (2022)
Dario Bongiovanni, Nina Schreiner, Rosanna Gosetti, Katharina Mayer, Dominick J Angiolillo, Dirk Sibbing, Stefan Holdenrieder, Aida Anetsberger, Moritz von Scheidt, Heribert Schunkert, Karl-Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, Isabel Wustrow, Isabell Bernlochner
Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy. Arteriosclerosis, thrombosis, and vascular biology 43 (2) (2022)
Luis Ortega-Paz, Dominick J Angiolillo
Optimal antiplatelet therapy in patients at high bleeding risk undergoing complex percutaneous coronary intervention. European heart journal 43 (33) (2022)
Amber L Beitelshees, Cameron D Thomas, Philip E Empey, George A Stouffer, Dominick J Angiolillo, Francesco Franchi, Sony Tuteja, Nita A Limdi, James C Lee, Julio D Duarte, Rolf P Kreutz, Todd C Skaar, James C Coons, Jay S Giri, Caitrin W McDonough, Rachel Rowland, James M Stevenson, Thuy Nhu Thai, Mark R Vesely, Jacob T Wellen, Julie A Johnson, Almut G Winterstein, Larisa H Cavallari, And Craig R Lee, null null
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings. Journal of the American Heart Association 11 (4) (2022)
Mattia Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi-Zoccai, Giovanni Maria Vescovo, Larisa H Cavallari, Behnood Bikdeli, Jurrien Ten Berg, Roxana Mehran, Charles Michael Gibson, Filippo Crea, Naveen L Pereira, Dirk Sibbing, Dominick J Angiolillo
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. European heart journal 43 (10) (2022)
Dominick J Angiolillo, Latonya Been, Marc Rubinstein, Michael Martin, Fabiana Rollini, Francesco Franchi
Use of the VerifyNow point of care assay to assess the pharmacodynamic effects of loading and maintenance dose regimens of prasugrel and ticagrelor. Journal of thrombosis and thrombolysis 51 (3) (2021)
Mattia Galli, Dominick J Angiolillo
Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope? European heart journal 42 (39) (2021)
Luis Ortega-Paz, Mattia Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C Michael Gibson, Renato D Lopes, Felicita Andreotti, Dominick J Angiolillo
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy (2021)
Davide Capodanno, Deepak L Bhatt, Charles Michael Gibson, Stefan K James, Takeshi Kimura, Roxana Mehran, Sunil V Rao, Philippe Gabriel Steg, Philip Urban, Marco Valgimigli, Stephan Windecker, Dominick J Angiolillo
Bleeding avoidance strategies in percutaneous coronary intervention. Nature reviews. Cardiology (2021)
Luis Ortega-Paz, Davide Capodanno, Dominick J Angiolillo
Canakinumab for secondary prevention of coronary artery disease. Future cardiology 17 (3) (2021)
Mattia Galli, Davide Capodanno, Stefano Benenati, Domenico D'Amario, Filippo Crea, Felicita Andreotti, Dominick J Angiolillo
Efficacy and safety of dual pathway inhibition in patients with cardiovascular disease: a systematic review and Meta-analysis. European heart journal. Cardiovascular pharmacotherapy (2021)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Larisa H Cavallari, Davide Capodanno, Filippo Crea, Dominick J Angiolillo
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations. Expert review of clinical pharmacology 14 (8) (2021)
Francesco Franchi, Fabiana Rollini, Latonya Been, Naji Maaliki, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Maryuri Briceno, Chang Hoon Lee, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Theodore A Bass, Dominick J Angiolillo
Impact Of Chronic Kidney Disease On The Pharmacodynamic And Pharmacokinetic Effects Of Ticagrelor In Patients With Diabetes Mellitus And Coronary Artery Disease. European heart journal. Cardiovascular pharmacotherapy (2021)
Dario Calderone, Salvatore Ingala, Maria Sara Mauro, Dominick J Angiolillo, Davide Capodanno
Appraising the contemporary role of aspirin for primary and secondary prevention of atherosclerotic cardiovascular events. Expert review of cardiovascular therapy 19 (12) (2021)
Dominick J Angiolillo, Deepak L Bhatt, Frank Lanza, Efthymios N Deliargyris, Jayne Prats, Weihong Fan, Upendra Marathi
Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation. Journal of thrombosis and thrombolysis 49 (3) (2021)
Piera Capranzano, Dominick J Angiolillo
Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention. Expert review of cardiovascular therapy 19 (6) (2021)
Paolo Calabrò, Felice Gragnano, Giampaolo Niccoli, Rossella Marcucci, Marco Zimarino, Carmen Spaccarotella, Giulia Renda, Giuseppe Patti, Giuseppe Andò, Elisabetta Moscarella, Massimo Mancone, Arturo Cesaro, Gennaro Giustino, Raffaele De Caterina, Roxana Mehran, Davide Capodanno, Marco Valgimigli, Stephan Windecker, George D Dangas, Ciro Indolfi, Dominick J Angiolillo
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease. Circulation 144 (16) (2021)
Davide Capodanno, Deepak L Bhatt, John W Eikelboom, Keith A A Fox, Tobias Geisler, Charles Michael Gibson, Jose Ramon Gonzalez-Juanatey, Stefan James, Renato D Lopes, Roxana Mehran, Gilles Montalescot, Manesh Patel, P Gabriel Steg, Robert F Storey, Pascal Vranckx, Jeffrey I Weitz, Robert Welsh, Uwe Zeymer, Dominick J Angiolillo
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease. Nature reviews. Cardiology 17 (4) (2020)
Davide Cao, Rishi Chandiramani, Davide Capodanno, Jeffrey S Berger, Matthew A Levin, Mary T Hawn, Dominick J Angiolillo, Roxana Mehran
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management. Nature reviews. Cardiology 18 (1) (2020)
Mattia Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea, Dominick J Angiolillo
Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert opinion on drug safety 20 (1) (2020)
Chang Hoon Lee, Francesco Franchi, Dominick J Angiolillo
Clopidogrel drug interactions: a review of the evidence and clinical implications. Expert opinion on drug metabolism & toxicology 16 (11) (2020)
Davide Capodanno, Rocco P Milluzzo, Dominick J Angiolillo
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use. Therapeutic advances in cardiovascular disease 13 (2020)
Dario Calderone, Davide Capodanno, Dominick J Angiolillo
An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus. Expert review of cardiovascular therapy 18 (8) (2020)
Dominick J Angiolillo, Deepak L Bhatt, Frank Lanza, Byron Cryer, Jin-Fei Dong, Walter Jeske, Ronald R Zimmerman, Estela von Chong, Jayne Prats, Efthymios N Deliargyris, Upendra Marathi
Pharmacokinetic/pharmacodynamic assessment of a novel, pharmaceutical lipid-aspirin complex: results of a randomized, crossover, bioequivalence study. Journal of thrombosis and thrombolysis 48 (4) (2020)
Sergio Buccheri, Dominick J Angiolillo, Davide Capodanno
Evolving paradigms in antithrombotic therapy for anticoagulated patients undergoing coronary stenting. Therapeutic advances in cardiovascular disease 13 (2019)
Sung Won Cho, Francesco Franchi, Dominick J Angiolillo
Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations. Therapeutic advances in hematology 10 (2019)